About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
- 2014 Rate Card & Production Specs
- 2013 Rate Card & Production Specs
- Advertising Due Dates
- BPA Statement
Statement of Purpose
Guidelines for Authors
Although warfarin and vitamin K antagonists have been a mainstay of therapy for preventing VTE and stroke, the risk of bleeding is a concern. Direct thrombin inhibitors, as well as factor Xa inhibitors, are discussed as promising replacements for warfarin.
Lisa R. Clayville, PharmD; Katherine Vogel Anderson, PharmD; Shannon A. Miller, PharmD; and Erin L. St. Onge, PharmD
Agents discussed at the conference included dasatinib (Sprycel), imatinib (Gleevec), nilotinib (Tasigna) pralatrexate (Fotolyn), zoledronic acid (Zometa), thalidomide combinations, lenalidomide (Revlimid), deferasirox (Exjade), eculizumab (Soliris), and salmalizumab for leukemias, myeloma, and other malignancies.
Topics include Gardasil vaccine for anal cancer; testosterone gel (Fortesta) for men with hypogonadism; and baclofen injection (Gablofen) for patients with spasticity.
Marvin M. Goldenberg, PhD, RPh, MS
Out of seven countries, the U.S. ranked last in quality of health care, according to four reports published since 2004.
David B. Nash, MD, MBA
To reduce the risk of health care–associated infections and mistakes in drug administration, medical staff members must make sure that intravenous (IV) tubing is capped correctly and that IV ports are properly sterilized.
Matthew Grissinger, RPh, FASCP
Medicare to Define Which Professionals Can Join in 2012
Medicare will launch a pilot program to determine the best form for Accountable Care Organizations. Pharmacy groups are begging for an invitation to the party.
FDA approvals, drug indications, and updates